The Closure of the Harvard Psilocybin Mushroom Project in 1962 ended a prominent university program but did not end the work of its founders. The project had brought psilocybin research into Harvard University; its shutdown followed a dispute over the university’s rules and sharpened the boundary between academic psychiatry and approaches to psychedelics that embraced spiritual experience and cultural change.

Establishment and Research

Founded in 1960 by Timothy Leary and Richard Alpert in Harvard University’s Department of Social Relations, the Harvard Psilocybin Project investigated the effects of psilocybin on hundreds of volunteers in naturalistic settings. Ralph Metzner, then a graduate student, was among the researchers. The group also conducted studies with prisoners at Concord State Prison and with theology students at Boston University’s Marsh Chapel, and later began working with LSD. Its program therefore reached beyond a single clinical setting, testing psychedelic drugs among different groups and in differing contexts.

Controversy and Closure

The project became engulfed in controversy in 1962. The account identifies the immediate issue as a report that Alpert had given psilocybin to an undergraduate, contrary to the agreement governing the project’s work with Harvard. The program was subsequently closed. The episode was not only a dispute about one researcher’s conduct: it exposed how fragile the project’s institutional standing was, and how closely access to university research depended on compliance with the university’s terms.

The shutdown came amid a larger professional unease about psychedelic therapy. In the mid-1950s, Humphry Osmond, Al Hubbard, and Aldous Huxley had advanced a model centered on a single high-dose session and a potentially transformative experience, rather than the familiar sequence of weekly psychotherapy sessions. To many academic psychiatrists, the spiritual dimensions of this approach blurred distinctions between religion and science, illness and health, and therapist and patient. The Harvard controversy thus unfolded within a field already divided over what counted as acceptable research and treatment.

Work Beyond Harvard

Leary and Alpert established a successor organization in Cambridge, outside Harvard: the International Federation for Internal Freedom. Their departure from the university therefore marked a change in the program’s institutional location, not an immediate end to their psychedelic work. The movement of research beyond Harvard also illustrates the tension at the heart of the episode: an inquiry that had begun within a major university continued through an organization no longer under its authority.

Legacy and Significance

The closure became one part of the longer history of psychedelic research’s movement between universities and less formal settings. Decades later, underground guides interviewed in the book could trace professional lineages to Leary, often through one of his graduate students, among other early psychedelic therapists. Myron Stolaroff also argued that the research revived in the late 1990s had developed partly from evidence gathered by underground therapists, alongside the first wave of research in the 1950s and 1960s. These later connections do not make the Harvard shutdown the sole cause of research’s subsequent path, but they show that closing the university project did not extinguish the practices and questions it had helped circulate.

The controversy also anticipates a methodological problem that remained salient in later clinical research: psychedelic effects are difficult to separate from the setting, the presence of guides, and participants’ expectations, while many participants can recognize whether they received the drug or a placebo. The Harvard project’s closure therefore carries significance beyond its institutional ending. It marks an early collision between psychedelic research and the boundaries through which universities and psychiatry sought to define scientific, therapeutic, and spiritual practice.